Literature DB >> 3361021

The microbiologic risk of invasive haemodynamic monitoring in open-heart patients requiring prolonged ICU treatment.

J Damen1.   

Abstract

The microbiologic risk of invasive haemodynamic monitoring and support was prospectively studied in 48 patients undergoing open-heart surgery under antibiotic prophylaxis and requiring intensive care for longer than 4 days. A total of 420 catheter tips were cultured of which 12 (2.9%) were positive. The incidence of positive catheter tip cultures was as follows: intravenous 1.8%, central venous 1.2%, arterial 1.8%, pulmonary arterial 5.9%, direct right atrial 2.4%, direct left atrial 0% and intra-aortic balloon pump catheters 7.7%. The rate of positive tip cultures was not significantly different for percutaneously and surgically inserted catheters (3.1% and 1.7% respectively). One (0.2%) catheter was associated with bacteraemia. Although the overall positive catheter tip culture rate was low, 21% of the patients had one or more positive catheter tip cultures. Complicated surgical procedures, a cardiopulmonary bypass time longer than 3.5 h, mechanical ventilation for more than 7 days, intensive care stay longer than 10 days, positive blood cultures and the use of more than 20 catheters were all individually associated with a significantly higher incidence of patients with positive tip cultures. Nevertheless, no patient developed endocarditis nor major morbidity related to the positive catheter tip cultures. Invasive haemodynamic monitoring does not seem to be an important microbiologic risk in open-heart patients requiring intensive care for longer than 4 days.

Entities:  

Mesh:

Year:  1988        PMID: 3361021     DOI: 10.1007/bf00257470

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  23 in total

Review 1.  Prosthetic valve infective endocarditis.

Authors:  C Watanakunakorn
Journal:  Prog Cardiovasc Dis       Date:  1979 Nov-Dec       Impact factor: 8.194

2.  Colonization of intravascular monitoring devices.

Authors:  W Samsoondar; J B Freeman
Journal:  Crit Care Med       Date:  1985-09       Impact factor: 7.598

3.  Contamination of internal jugular lines. Incidence in patients undergoing open-heart surgery.

Authors:  J C Opie
Journal:  Anaesthesia       Date:  1980-11       Impact factor: 6.955

4.  A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection.

Authors:  D G Maki; J D Band
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

5.  Nosocomial infections in intensive care wards: a multicenter prospective study.

Authors:  F D Daschner; P Frey; G Wolff; P C Baumann; P Suter
Journal:  Intensive Care Med       Date:  1982-01       Impact factor: 17.440

6.  Microbiologic risk of invasive hemodynamic monitoring in patients undergoing open-heart operations.

Authors:  J Damen; J Verhoef; D T Bolton; N G Middleton; I van der Tweel; K de Jonge; J E Wever; M Nijsen-Karelse
Journal:  Crit Care Med       Date:  1985-07       Impact factor: 7.598

7.  Protection of indwelling vascular catheters: incidence of bacterial contamination and catheter-related sepsis.

Authors:  P Ricard; R Martin; J A Marcoux
Journal:  Crit Care Med       Date:  1985-07       Impact factor: 7.598

8.  Catheter tip cultures on open-heart surgery patients: associations with site of catheter and age of patients.

Authors:  R Freeman; N Hjersing; A Burridge
Journal:  Thorax       Date:  1981-05       Impact factor: 9.139

9.  Septicaemia in a medical intensive care unit. Clinical, biochemical and microbiological data of 109 cases.

Authors:  E Domínguez de Villota; A Algora; J J Rubio; M Roig; J M Mosquera; P Galdos; V Díez-Balda
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

10.  Risk factors related to bacterial contamination of indwelling vascular catheters in non-infected hosts.

Authors:  A R Essop; J Frolich; M R Moosa; M Miller; R C Ming
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.